Document Detail

Effect of O6-benzylguanine on alkylating agent-induced toxicity and mutagenicity. In Chinese hamster ovary cells expressing wild-type and mutant O6-alkylguanine-DNA alkyltransferases.
MedLine Citation:
PMID:  11034089     Owner:  NLM     Status:  MEDLINE    
The DNA repair protein O6-alkylguanine-DNA alkyltransferase (AGT) has been shown to protect cells from the toxic and mutagenic effect of alkylating agents by removing lesions from the O6 position of guanine. O6-Benzylguanine (BG) is a potent inactivator of AGT, resulting in an increase in the sensitivity of cells to the toxic effects of chemotherapeutic alkylating agents. Chinese hamster ovary (CHO) cells and CHO cells transfected with wild-type AGT (CHOWTAGT) and a mutant AGT [P138 M/V139I/P140K (CHOMIK)] known to be resistant to BG were treated with BG and various alkylating agents. BG treatment alone dramatically decreased AGT activity in CHOWTAGT cells but resulted in no depletion in AGT activity in CHOMIK cells. In the absence of AGT, these cells are highly sensitive to the toxic and mutagenic effects of temozolomide and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), and no further sensitization occurs in the presence of BG. In contrast, CHOWTAGT cells are resistant to temozolomide and BCNU, and treatment with BG resulted in a significantly higher cell killing and mutation frequency. CHOMIK cells were completely resistant to temozolomide or BCNU in the presence and absence of BG. Both cell killing and mutation frequency of 4-hydroperoxycyclophosphamide (4-HC) in CHO, CHOWTAGT, and CHOMIK cells were increased in the presence of BG. 4-HC generates two active metabolites, phosphoramide mustard (PM) and acrolein. BG had no effect on 4hydroperoxydidechlorocyclophosphamide (which generates acrolein and a nonalkylating form of PM) in CHO cells and CHOMIK cells, but enhancement of toxicity was observed with PM in both these cell lines. Therefore, we attribute the enhancement to the PM metabolite of 4-HC. Our results demonstrate that wild-type AGT plays an important role in protecting against the toxic and mutagenic effect of O6 alkylating agents and that a mutant AGT resistant to inactivation by BG effectively prevents BG-enhanced toxicity and mutagenicity induced by these agents. Expression of the AGT protein contributes to resistance of 4-HC. BG also enhances the toxicity of 4-HC and PM by a mechanism that may not involve the AGT repair protein.
Y Cai; M H Wu; M Xu-Welliver; A E Pegg; S M Ludeman; M E Dolan
Related Documents :
7407919 - Cho cells selected for phytohemagglutinin and con a resistance are defective in both ea...
2300069 - Effects of trypsin on x-ray-induced cell killing, chromosome abnormalities and kinetics...
10332809 - Antimutagenic activity of chemical fractions isolated from a commercial soybean process...
2885329 - Thermolabile proton translocating atpase and pump activities in a clathrin-coated vesic...
1505529 - Comparison of rat liver parenchymal and nonparenchymal cells in the activation of promu...
8942999 - Recurrent g-to-a substitution in a single codon of srebp cleavage-activating protein ca...
9082989 - Wound healing--aiming for perfect skin regeneration.
1580099 - Flow cytometric analysis of saccharomyces cerevisiae autolytic mutants and protoplasts.
16200199 - Endoplasmic reticulum stress: cell life and death decisions.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Cancer research     Volume:  60     ISSN:  0008-5472     ISO Abbreviation:  Cancer Res.     Publication Date:  2000 Oct 
Date Detail:
Created Date:  2000-10-16     Completed Date:  2000-10-27     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  2984705R     Medline TA:  Cancer Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  5464-9     Citation Subset:  IM    
Department of Medicine University of Chicago, Illinois 60637, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antineoplastic Agents, Alkylating / toxicity*
CHO Cells / drug effects,  enzymology
Carmustine / toxicity
Cyclophosphamide / analogs & derivatives*,  toxicity
Dacarbazine / analogs & derivatives*,  toxicity
Drug Interactions
Enzyme Inhibitors / toxicity*
Guanine / analogs & derivatives*,  toxicity*
Mutagenicity Tests
Mutagens / toxicity
O(6)-Methylguanine-DNA Methyltransferase / antagonists & inhibitors,  genetics,  metabolism*
Grant Support
Reg. No./Substance:
0/Antineoplastic Agents, Alkylating; 0/Enzyme Inhibitors; 0/Mutagens; 154-93-8/Carmustine; 19916-73-5/O(6)-benzylguanine; 39800-16-3/perfosfamide; 4342-03-4/Dacarbazine; 50-18-0/Cyclophosphamide; 73-40-5/Guanine; 85622-93-1/temozolomide; EC Methyltransferase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against...
Next Document:  Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion o...